APPLICATIONS PUBLISHED 28 MAY 2003
Published: 1-Nov-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Palatable oral coenzyme Q liquid
Chopra, Raj K 1313447*
Topical aminolevulinic acid-photodynamic therapy for acne vulgaris
The General Hospital doing business as Massachusetts General Hospital 1313448*
Amphotericin B structured emulsion
Bharat Serums & Vaccines 1313449*
A method of treating a systemic disease
Aeropharm Technology Corp 1313450*
Milled particles
RTP Pharma 1313451*
Solid peptide preparations for inhalation, and the production thereof
Sofotec 1313452*
Particulate vectors for improving oral absorption of active principles
Maincent, Phillippe; Ubrich, Nathalie; Vigneron, Claude 1313453*
Polymeric compsns and a method of making the same
Abbott Laboratories 1313454*
Controlled and sustained release properties of polyelectrolyte multilayer capsules
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1313455*
Intradermal penetration agents for topical local anaesthetic administration
EpiCept Corp 1313456*
Transdermal therapeutic system for releasing venlafaxine
LTS Lohmann Therapie-Systeme 1313457*
Gene conferring resistance to the antibacterial 4,5-dihydroxy-2-cyclopenten-1-one (DHCP), the protein encoded by same, and applications thereof
Takara Shuzo 1313458*
Polycyclic dianthorquinones as anti-cancer and anti-angiogenic agents
Yeda Research and Development; New York University Medical Center 1313459*
Therapeutic user and formulation of (-)-tramadol
Darwin Discovery 1313460*
The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
Melacure Therapeutics 1313461*
Use of asiatic acid or asiaticoside for treatment of cancer
Government of Malaysia, Ministry of Science, Technology and the Environment; Massachusetts Institute of Technology 1313462*
Fatty acid analogues for the treatment of cancer
Thia Medica 1313463*
Method for treatment of reactive arthritis or bursitis
Bonner, Ernest Jr; Hines, Robert 1313464*
Compsn and method for treatment of hypertriglyceridemia
Pilot Therapeutics 1313465*
Bimodal emulsions of taxanes and butyrate polyalcoholesters
Atossa Healthcare 1313466*
Novel pharmaceutical compsn for administering N-0923
Schwartz Pharma 1313467*
Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors
Boehringer Ingelheim Pharma 1313468*
Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
Ribapharm 1313469*
Novel acyclic imidazoles as H3 agents
Gliatech 1313470*
Benzylidene thiazolidinediones and their use as antimycotic agents
Oxford Glycosciences 1313471*
Method for reducing or eliminating smoking
SmithKline Beecham 1313472*
Sustained release formulations for growth hormone secretagogues
Pfizer Products 1313473*
Paroxetine compsns and processes for making the same
Synthon 1313474*
Anti-cancer compsn composed of anti-cancer and anti-malarial drugs
Keum, Ki-Chang; Yoo, Nae-Choon; Yoo, Won-Min 1313475*
SGK2 and SGK3 used as diagnostic and therapeutic targets
Lang, Florian 1313476*
Compounds and methods
SmithKline Beecham 1313477*
Method for treatment of migraine using PDE5 inhibitors
Lilly Icos 1313478*
Hair loss prevention
Knowles, W Roay 1313479*
Use of an arylaldehyde 5-oxo-1,2,4-triazine hydrazine for the treatment of cancer
Procter & Gamble 1313480*
Pharmaceutical compsn comprising condensed indole compound
SmithKline Beecham 1313481*
Pharmaceutical compsn and method for treating hypogonadism
Unimed Pharmaceuticals; Laboratoires Besins Iscovesco 1313482*
Methods for inducing apolipoprotein E secretion
Symphar 1313483*
Pharmaceutical formulation of salmeterol and fluticasone propionate
Glaxo 1313484*
Use of an aldosterone receptor antagonist to improve cognitive function
Pharmacia 1313485*
Processes for preparing clarythromycin and clarythromycin intermediate, essentially oxime-free clarythromycin, and pharmaceutical compsn comprising the same
Teva Pharmaceutical Industries 1313486*
Water-soluble amide derivatives of polymer macrolides and preparation and uses thereof
IntraBiotics Pharmaceuticals 1313487*
Compsns and methods for improving cardiovascular function
Bioenergy 1313488*
Pharmaceutical compsns for the treatment of mucositis, stomatitis and Behcet's syndrome
Sinclair Pharmaceuticals 1313489*
Pharmaceutical compsn comprising wikstromol and/or matairesinol, its use as hepatoprotectant and process for their isolation from Cedrus deodara
Council of Industrial and Scientific Research; Tiwari, Ashok Kumar 1313490*
Bioactive fraction of Eurycomoa longifolia
Government of Malaysia, Ministry of Science, Technology and the Environment; Massachusetts Institute of Technology 1313491*
Use of a compsn comprising extract of pollen for the treatment of dysphoria
Nutamin Pharma 1313492*
Use of a compsn comprising extract of pollen for the treatment of irritability
Nutamin Pharma 1313493*
Use of a compsn comprising extract of pollen for the treatment of hormonally-related disorders
Natumin Pharma 1313495*
Use of a compsn comprising an extract of pollen for the treatment of oedema
Natumin Pharma 1313496*
Use of extracts of the Cassia alata plant
Cognis France 1313497*
Phospholipase D effectors for therapy and screening
Williger, Ben-Tsion 1313498*
Method for treating the central nervous system by administration of IGF structural analogues
Colorado State University Research Foundation 1313499*
Functions for DP214
DeveloGen Aktiengesellschaft fuer entwicklungsbiologische Forschung 1313501*
Method of administering FIMH protein as a vaccine for urinary tract infections
Medimmune 1313502*
Human tumour necrosis factor receptors TR21 and TR22
Human Genome Sciences 1313503*
Methods and compsns for inhibiting angiogenesis
Philadelphia, Health and Education Corporation 1313504*
HLA binding peptides and their uses
Epimmune 1313505*
Immunologic method for the prevention of dental caries
Washington Dental Services 1313506*
Modulators of intermediate conductance calcium-activated potassium (IKCA) channel activity for treating sexual dysfunction
Pfizer 1313507*
Combination containing an antifolate and methylmalonic acid lowering agent
Eli Lilly 1313508*
Treatment of tumours with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumour agents
Allergan 1313509*
Novel pharmaceutical compsn
Schwarz Pharma 1313510*
Testosterone ester formulation for human use
Akzo Nobel 1313511*
Vascular endothelial growth factor 2
Human Genome Sciences 1313512*
Identification, diagnosis, and treatment of breast cancer
Cytyc Health Corp 1313513*
Methods of treatment of a BCL-2 disorder using BCL-2 antisense oligomers
Genta Inc 1313514*
Methods and agents for cleaning and disinfecting fragile medical appliances
Escolab 1313515*
Antimicrobial material for implanting in bones
Bio-Gate Bioinnovative Materials 1313518*
